Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis

ανά Hsiao, J-R, Jin, Y-T, Tsai, S-T, Shiau, A-L, Wu, C-L, Su, W-C
Έκδοση 2003

Sp1 expression regulates lung tumor progression

ανά Hsu, T-I, Wang, M-C, Chen, S-Y, Yeh, Y-M, Su, W-C, Chang, W-C, Hung, J-J
Έκδοση 2012

EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis

ανά Wang, S-A, Wang, Y-C, Chuang, Y-P, Huang, Y-H, Su, W-C, Chang, W-C, Hung, J-J
Τόπος έκδοσης Oncogene (2017)

A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer

ανά Ko, A H, Tempero, M A, Shan, Y-S, Su, W-C, Lin, Y-L, Dito, E, Ong, A, Wang, Y-W, Yeh, C G, Chen, L-T
Έκδοση 2013

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

ανά Chao, Y, Li, C P, Chao, T Y, Su, W C, Hsieh, R K, Wu, M F, Yeh, K H, Kao, W Y, Chen, L T, Cheng, A L
Έκδοση 2006

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

ανά Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T.-S., Su, W.-C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y., Van Cutsem, E.
Τόπος έκδοσης Ann Oncol (2017)

Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma

ανά Chuang, J-Y, Lo, W-L, Ko, C-Y, Chou, S-Y, Chen, R-M, Chang, K-Y, Hung, J-J, Su, W-C, Chang, W-C, Hsu, T-I
Τόπος έκδοσης Oncogenesis (2017)

Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer

ανά Jen, J, Lin, L-L, Chen, H-T, Liao, S-Y, Lo, F-Y, Tang, Y-A, Su, W-C, Salgia, R, Hsu, C-L, Huang, H-C, Juan, H-F, Wang, Y-C
Τόπος έκδοσης Oncogene (2016)

Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer

ανά Jen, J, Lin, L-L, Lo, F-Y, Chen, H-T, Liao, S-Y, Tang, Y-A, Su, W-C, Salgia, R, Hsu, C-L, Huang, H-C, Juan, H-F, Wang, Y-C
Τόπος έκδοσης Oncogene (2017)

Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer

ανά Jen, J, Lin, L-L, Lo, F-Y, Chen, H-T, Liao, S-Y, Tang, Y-A, Su, W-C, Salgia, R, Hsu, C-L, Huang, H-C, Juan, H-F, Wang, Y-C
Τόπος έκδοσης Oncogene (2017)

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies

ανά Lin, C-C, Su, W-C, Yen, C-J, Hsu, C-H, Su, W-P, Yeh, K-H, Lu, Y-S, Cheng, A-L, Huang, D C-L, Fritsch, H, Voss, F, Taube, T, Yang, J C-H
Έκδοση 2014

Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomiz...

ανά De Santis, M., Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W.-C., Albiges, L., Lin, C.-C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N., Culine, S.
Τόπος έκδοσης Ann Oncol (2016)

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

ανά Gerber, D E, Horn, L, Boyer, M, Sanborn, R, Natale, R, Palmero, R, Bidoli, P, Bondarenko, I, Germonpre, P, Ghizdavescu, D, Kotsakis, A, Lena, H, Losonczy, G, Park, K, Su, W -C, Tang, M, Lai, J, Kallinteris, N L, Shan, J S, Reck, M, Spigel, D R
Τόπος έκδοσης Ann Oncol (2018)